Interní Med. 2013; 15(2): 64-68

Insulin pump therapy

doc.MUDr.Kateřina Štechová, Ph.D.
Pediatrická klinika UK 2. LF a FN v Motole, Praha

The course of glycaemia near to normal values is the key goal in diabetes therapy to improve importantly patient´s long term outcome.

Insulin pump therapy which means combination of permanent slow subcutaneous infusion of basal insulin dose according to prepared

schema in combination with manually activated prandial boluses represents nowadays the best possibility how to mimic physiological

insulin secretion. New insulin pumps have integrated many modern tools (e.g. the possibility to choose different types of basal and bolus

doses, bolus calculator or integrated system of continual glucose monitoring). By using these tools a patient can improve his or her diabetes

stabilisation importantly and it is possible to prevent or at least to slow or moderate the course of chronic diabetic complications. It

is necessary to stress that this therapy improve overall patient´s life quality as well. To reach this goal it is necessary to educate and even

more – to motivate patients as well as health care professionals. This article should inform you on this therapy which is an expensive but

very efficient tool in diabetes treatment.

Keywords: diabetes, insulin pump, normoglycaemia, continuous subcutaneous insulin infusion

Published: March 8, 2013  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Štechová K. Insulin pump therapy. Interní Med. 2013;15(2):64-68.
Download citation

References

  1. American Diabetes Association. Diagnosis and Classification of Diabetes Mellitus. Position statement. Diabetes Care, vol.35, Supplement 1, January 2012: S64-S71. Go to original source... Go to PubMed...
  2. Bartášková D, Kožnarová R, Kvapil M. Pilotní analýza farmakoekonomických aspektů léčby diabetes mellitus v České republice. Remedia 2004; 14: 377-384.
  3. Danne T, et al. Establishing glycaemic control with continuous subcutaneous insulin infusion in children and adolescents with type 1 diabetes: experience of the PedPump Study in 17 countries. Diabetologia. 2008 Sep; 51(9): 1594-1601. Go to original source... Go to PubMed...
  4. Jankovec Z, Hahn M, Grunder S, Lacigova S, Cechurova D, Krcma M, Zourek M, Haladova I, Rusavy Z. Analysis of continuous patient data from the Czech National Register of patients with type 1 and type 2 diabetes using insulin pump therapy. Diab. Res.Clin. Pract. 2010; 87(2): 219-223. Go to original source... Go to PubMed...
  5. Klupa T, Skupien J, Cyganek K, Katra B, Sieradzki J, Malecki MT. The dual-wave bolus feature in type 1 diabetes adult users of insulin pumps. Acta Diabetol. 2011 Mar; 48(1): 11-14. Go to original source... Go to PubMed...
  6. Lee SW, Cao M, Sajid S, Hayes M, Choi L, Rother C, de León R. The dual-wave bolus feature in continuous subcutaneous insulin infusion pumps controls prolonged post-prandial hyperglycaemia better than standard bolus in Type 1 diabetes. Diabetes Nutr Metab. 2004 Aug; 17(4): 211-216.
  7. Leinung M, Thompson S, Nardacci E. Benefits of continuous glucose monitor use in clinical practice. Endocr Pract. 2010 May-Jun; 16(3): 371-375. Go to original source... Go to PubMed...
  8. Pańkowska E, Błazik M. Bolus calculator with nutrition database software, a new concept of prandial insulin programming for pump users. J Diabetes Sci Technol. 2010 May 1; 4(3): 571-576. Go to original source... Go to PubMed...
  9. Pickup JC. Insulin-pump therapy for type 1 diabetes mellitus. N Engl J Med. 2012 Apr 26; 366(17): 1616-1624. Go to original source... Go to PubMed...
  10. Piťhová P a Štechová K. Léčba inzulinovou pumpou pro praxi. Praha: Geum 2009: 62-75.
  11. Piťhová P a Štechová K. Léčba inzulinovou pumpou pro praxi. Praha: Geum 2009: 120-134 a 167-170.
  12. Piťhová P a Štechová K. Léčba inzulinovou pumpou pro praxi. Praha: Geum 2009: 135-153.
  13. Piťhová P a Štechová K. Léčba inzulinovou pumpou pro praxi. Praha: Geum 2009: 175-180.
  14. P?rksen N, Hollingdal M, Juhl C, Butler P, Veldhuis JD, Schmitz O. Pulsatile insulin secretion: detection, regulation, and role in diabetes. Diabetes. 2002 Feb; 51(Suppl 1): S245-254. Go to original source... Go to PubMed...
  15. Renard E. Intensive insulin therapy today:, basal-bolus' using multiple daily injections or CSII? Diabetes Metab. 2005 Sep; 31(4 Pt 2): 4S40-4S44. Go to original source... Go to PubMed...
  16. Rušavý Z, Jirkovská A. Doporučený postup léčby inzulinovou pumpou (continuous subcutaneous insulin infusion - CSII). Standard léčby pumpou. Česká diabetologická společnost. http://www.diab.cz/standardy.




Internal Medicine for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.